BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1865744)

  • 21. Increased stability of airflow following botulinum toxin injection.
    Finnegan EM; Luschei ES; Gordon JD; Barkmeier JM; Hoffman HT
    Laryngoscope; 1999 Aug; 109(8):1300-6. PubMed ID: 10443837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin for spasmodic dysphonia.
    Rodriquez AA
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of phonosurgical methods of treatment in spasmodic dysphonia].
    Kosztyła-Hojna B; Berger G; Zdrojkowski M
    Pol Merkur Lekarski; 2017 Feb; 42(248):90-92. PubMed ID: 28258685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum Toxin Injections Into the Lateral Cricoarytenoid Muscles for Vocal Process Granuloma.
    Pham Q; Campbell R; Mattioni J; Sataloff R
    J Voice; 2018 May; 32(3):363-366. PubMed ID: 28778373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.
    Truong DD; Bhidayasiri R
    Eur J Neurol; 2006 Feb; 13 Suppl 1():36-41. PubMed ID: 16417596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.
    Cannito MP; Kahane JC; Chorna L
    Clin Interv Aging; 2008; 3(1):131-51. PubMed ID: 18488884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin injections for the treatment of spasmodic dysphonia.
    Watts CC; Whurr R; Nye C
    Cochrane Database Syst Rev; 2004; 2004(3):CD004327. PubMed ID: 15266530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].
    Schwemmle C; Ptok M
    HNO; 2007 May; 55(5):399-402. PubMed ID: 17431567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary management of spasmodic dysphonia.
    Sulica L
    Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):543-8. PubMed ID: 15548915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology].
    Ptok M; Schönweiler R; Nawka T;
    HNO; 2004 Jan; 52(1):45-9. PubMed ID: 14740114
    [No Abstract]   [Full Text] [Related]  

  • 32. Spasmodic dysphonia: let's look at that again.
    Murry T
    J Voice; 2014 Nov; 28(6):694-9. PubMed ID: 24972536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Movement Disorders and Voice.
    Snow G; Guardiani E
    Otolaryngol Clin North Am; 2019 Aug; 52(4):759-767. PubMed ID: 31076164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of laryngeal movement disorders with botulinum toxin: part 2: experience and considerations].
    Schwemmle C; Ptok M
    HNO; 2007 Jun; 55(6):485-8. PubMed ID: 17431566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum A toxin in spasmodic torticollis.
    Ellison DC; Wandres DL
    Ann Pharmacother; 1992 Feb; 26(2):216-7. PubMed ID: 1554937
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs.
    Watts CR; Truong DD; Nye C
    J Neural Transm (Vienna); 2008; 115(4):625-30. PubMed ID: 17564757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice parameter: laryngeal electromyography (an evidence-based review).
    Sataloff RT; Mandel S; Mann EA; Ludlow CL
    J Voice; 2004 Jun; 18(2):261-74. PubMed ID: 15193662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spasmodic dysphonia: new diagnosis and treatment opportunities.
    Cook MJ; Lewin JS
    Nurse Pract; 1994 Sep; 19(9):67-73. PubMed ID: 7816374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.
    Hyodo M; Asano K; Nagao A; Hirose K; Nakahira M; Yanagida S; Nishizawa N
    Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laryngeal electromyography: an evidence-based review.
    Sataloff RT; Mandel S; Mann EA; Ludlow CL;
    Muscle Nerve; 2003 Dec; 28(6):767-72. PubMed ID: 14639595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.